Oncology Central

Palbociclib halts tumor growth in early breast cancer patients

0
Recently published in the Journal of Clinical Oncology ,researchers from the Institute of Cancer Research (London, UK) and The Royal Marsden NHS Foundation Trust (London) have demonstrated that palbociclib alongside an aromatase inhibitor shrank tumors in half of women with early-stage breast cancer and stopped tumor growth entirely in 90% of women.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.

Share:

Insights

Videos

News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.